02 Jun 2014
A study presented at the American Society of Clinical Oncology has been in the news for showing that women with early-stage breast cancer receiving the GnRH agonist goserelin along with chemotherapy were 64% less likely to develop early menopause than women who had chemotherapy alone, preserving their ability to have children.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024